pembrolizumab/axitinib and avelumab/axitinib combo for rcc
Published 5 years ago • 211 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
2:31
axitinib plus pembrolizumab in advanced rcc
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc
-
2:27
combining avelumab and axitinib in advanced renal cell carcinoma (rcc)
-
4:25
kidney cancer updates: avelumab/axitinib, pembro/axitinib, bevacizumab/atezo & ipilimumab/nivo
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
5:10
real-world treatment outcomes of 1l axitinib pembrolizumab in patients with advanced rcc in the us
-
0:44
real-world efficacy of avelumab and axitinib in advanced renal cell carcinoma
-
0:57
avelumab and axitinib for the treatment of advanced rcc
-
1:06
exciting potential of pembrolizumab combined with axitinib for kidney cancer
-
3:41
tide-a: avelumab and intermittent axitinib in metastatic renal cell carcinoma
-
1:37
dr. shuch on caveats of avelumab/axitinib combination in rcc
-
2:31
recent immunotherapy advances in rcc
-
4:47
keynote-426 - pembrolizumab plus axitinib versus sunitinib for mrcc
-
1:19
dr. rini on the efficacy of axitinib and pembrolizumab in rcc
-
1:24
final results of avelumab and axitinib in rcc in the javelin renal 101 trial
-
1:29
phase i/ii study of nivolumab and axitinib for advanced rcc
-
1:17
dr. vaishampayan on axitinib plus pembrolizumab in advanced rcc
-
3:18
exploring the combination of first-line avelumab/axitinib in hcc
-
2:16
treating kidney cancer with axitinib &avelumab, or axitinib & pembrolizumab?